Global Embolic Protection Devices Market Report By Product (Distal Occlusion Filters, Proximal Occlusion Filters, And Distal Filters), Application (Neurovascular Diseases, Cardiovascular Diseases, And Peripheral Vascular Diseases) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210453

January 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study the Global Embolic Protection Devices Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Embolic protection devices or EPDs are braided nitinol basket, available in a number of sizes for optimal vessel sizing. EPDs are primarily used during percutaneous cardiac procedures. But it also supports in reducing a number of complications, which arise due to blockages in small blood vessels caused by the debris that is released into the bloodstream.

Market Dynamics

The rising incidence of cardiovascular and neurovascular diseases across the globe is driving the demand of embolic protection devices. Increasing investments on advanced EPDs and rising demand of minimal invasive devices for the treatment is another major factor fuelling the market growth. Also, ongoing R&D by major players to overcome the limitations such as pricing pressure by large chain hospitals is expected to boost the market in upcoming years. However, product failure and recalls are likely to restrict the market growth to a certain extent during the forecast period.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of embolic protection devices.

Market Segmentation

The broad embolic protection devices market has been sub-grouped into product and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Product

Distal Occlusion Filters
Proximal Occlusion Filters
Distal Filters

By Application

Neurovascular Diseases
Cardiovascular Diseases
Peripheral Vascular Diseases

Regional Analysis

Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for embolic protection devices in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Embolic Protection Devices Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the embolic protection devices market include Abbott Laboratories, Allium Medical, Boston Scientific Corp., Cardinal Health, Claret Medical, Inc., Edward Lifesciences, Gore Medical, Innovative Cardiovascular Solutions, LLC, Medtronic Plc and Transverse Medical, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Clinical Trials Management System Market
       2.2. Global Clinical Trials Management System Market Snapshot

3 . CLINICAL TRIALS MANAGEMENT SYSTEM – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Clinical Trials Management System Market
       3.3. Market Restraints of Clinical Trials Management System Market
       3.4. Opportunities of Clinical Trials Management System Market
       3.5. Trends of Clinical Trials Management System Market
      3.6. Porter’s Five Force Analysis of Clinical Trials Management System Market
       3.7. Clinical Trials Management System Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Clinical Trials Management System Value Chain Analysis
       4.2. Clinical Trials Management System Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Clinical Trials Management System Raw Material Manufactures List
           4.2.3. Price Trend of Clinical Trials Management System Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Clinical Trials Management System Market Analysis by Product
       5.3 Market Analysis of Distal Occlusion Filters by Regions
       5.4 Market Analysis of Proximal Occlusion Filters by Regions
       5.5 Market Analysis of Distal Filters by Regions

6 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Clinical Trials Management System Market Analysis by Application
       6.3 Market Analysis of Neurovascular Diseases by Regions
       6.4 Market Analysis of Cardiovascular Diseases by Regions
       6.5 Market Analysis of Peripheral Vascular Diseases by Regions

7 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Clinical Trials Management System Market Estimate by Market Segment
           7.3.3. North America Clinical Trials Management System Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Clinical Trials Management System Market Estimate by Market Segment
           7.4.3. Europe Clinical Trials Management System Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Clinical Trials Management System Market Estimate by Market Segment
           7.5.3. Asia Pacific Clinical Trials Management System Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Clinical Trials Management System Market Estimate by Market Segment
           7.6.3. Latin America Clinical Trials Management System Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Clinical Trials Management System Market Estimate by Market Segment
           7.7.3. Middle East & Africa Clinical Trials Management System Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS MANAGEMENT SYSTEM COMPANIES
       8.1. Clinical Trials Management System Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments

9 . COMPANY PROFILES OF CLINICAL TRIALS MANAGEMENT SYSTEM INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Abbott Laboratories
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Allium Medical
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Boston Scientific Corp.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Cardinal Health
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Claret Medical, Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Edward Lifesciences
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Gore Medical
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Innovative Cardiovascular Solutions, LLC
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Medtronic Plc
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Transverse Medical, Inc.
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK
10.1. Impact Analysis of Covid-19 Outbreak on the Market
10.1.1. Direct Impact on Production
10.1.2. Supply Chain and Market Disruption
10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Clinical Trials Management System Report
Market Research Process
Market Research Methodology
Global Clinical Trials Management System Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Clinical Trials Management System Market Analysis by Product (USD MN)
Global Clinical Trials Management System Market Analysis in Distal Occlusion Filters by Geography (USD MN)
Global Clinical Trials Management System Market Analysis in Proximal Occlusion Filters by Geography (USD MN)
Global Clinical Trials Management System Market Analysis in Distal Filters by Geography (USD MN)
Global Clinical Trials Management System Market Analysis by Application (USD MN)
Global Clinical Trials Management System Market Analysis in Neurovascular Diseases by Geography (USD MN)
Global Clinical Trials Management System Market Analysis in Cardiovascular Diseases by Geography (USD MN)
Global Clinical Trials Management System Market Analysis in Peripheral Vascular Diseases by Geography (USD MN)
Latin America Clinical Trials Management System Market by Revenue
Middle East & Africa Clinical Trials Management System Market by Revenue
Recent Development in Clinical Trials Management System Industry
Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11210453

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

ID:VMR11210453

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact